Optimal adjuvant chemotherapy for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis

Adjuvant chemotherapy improves survival in patients with resected pancreatic cancer but the optimal regimen remains unclear. We aim to compare all possible adjuvant chemotherapy in terms of overall survival and toxic effects. Pubmed, Trial registries and Cochrane library databases for randomized con...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian-Bo, Jiang, Bin, Chen, Ya, Qi, Fu-Zhen, Zhang, Jian-Huai, Yuan, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655296/
https://www.ncbi.nlm.nih.gov/pubmed/29113401
http://dx.doi.org/10.18632/oncotarget.19082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655296/
https://www.ncbi.nlm.nih.gov/pubmed/29113401
http://dx.doi.org/10.18632/oncotarget.19082

Ejemplares similares